Design and Immunogenicity of SARS-CoV-2 DNA Vaccine Encoding RBD-PVXCP Fusion Protein

The potential of immune-evasive mutation accumulation in the SARS-CoV-2 virus has led to its rapid spread, causing over 600 million confirmed cases and more than 6.5 million confirmed deaths. The huge demand for the rapid development and deployment of low-cost and effective vaccines against emerging...

Descripción completa

Detalles Bibliográficos
Autores principales: Dormeshkin, Dmitri, Katsin, Mikalai, Stegantseva, Maria, Golenchenko, Sergey, Shapira, Michail, Dubovik, Simon, Lutskovich, Dzmitry, Kavaleuski, Anton, Meleshko, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300735/
https://www.ncbi.nlm.nih.gov/pubmed/37376403
http://dx.doi.org/10.3390/vaccines11061014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300735/
https://www.ncbi.nlm.nih.gov/pubmed/37376403
http://dx.doi.org/10.3390/vaccines11061014

Ejemplares similares